{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T01:23:24Z","timestamp":1768094604229,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although age, obesity and pre-existing chronic diseases are established risk factors for COVID-19 outcomes, their interactions have not been well researched.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used data from the Clinical Characterisation Protocol UK (CCP-UK) for Severe Emerging Infection developed by the International Severe Acute Respiratory and emerging Infections Consortium (ISARIC). Patients admitted to hospital with COVID-19 from 6th February to 12th October 2020 were included where there was a coded outcome following hospital admission. Obesity was determined by an assessment from a clinician and chronic disease by medical records. Chronic diseases included: chronic cardiac disease, hypertension, chronic kidney disease, chronic pulmonary disease, diabetes and cancer. Mutually exclusive categories of obesity, with or without chronic disease, were created. Associations with in-hospital mortality were examined across sex and age categories.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The analysis included 27,624 women with 6407 (23.2%) in-hospital deaths and 35,065 men with 10,001 (28.5%) in-hospital deaths. The prevalence of chronic disease in women and men was 66.3 and 68.5%, respectively, while that of obesity was 12.9 and 11.1%, respectively. Association of obesity and chronic disease status varied by age (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Under 50\u2009years of age, obesity and chronic disease were associated with in-hospital mortality within 28\u2009days of admission in a dose-response manner, such that patients with both obesity and chronic disease had the highest risk with a hazard ratio (HR) of in-hospital mortality of 2.99 (95% CI: 2.12, 4.21) in men and 2.16 (1.42, 3.26) in women compared to patients without obesity or chronic disease. Between the ages of 50\u201369\u2009years, obesity and chronic disease remained associated with in-hospital COVID-19 mortality, but survival in those with obesity was similar to those with and without prevalent chronic disease. Beyond the age of 70\u2009years in men and 80\u2009years in women there was no meaningful difference between those with and without obesity and\/or chronic disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Obesity and chronic disease are important risk factors for in-hospital mortality in younger age groups, with the combination of chronic disease and obesity being particularly important in those under 50\u2009years of age. These findings have implications for targeted public health interventions, vaccination strategies and in-hospital clinical decision making.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06466-0","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T04:15:09Z","timestamp":1627704909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Obesity, chronic disease, age, and in-hospital mortality in patients with covid-19: analysis of ISARIC clinical characterisation protocol UK cohort"],"prefix":"10.1186","volume":"21","author":[{"given":"Thomas","family":"Yates","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Zaccardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazrul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron","family":"Razieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare L.","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire A.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogini","family":"Chudasama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Rowlands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie J.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemarie B.","family":"Docherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J. M.","family":"Openshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Kenneth","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm G.","family":"Semple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,31]]},"reference":[{"issue":"Suppl 3","key":"6466_CR1","doi-asserted-by":"publisher","first-page":"S304","DOI":"10.1016\/j.jcot.2020.04.030","volume":"11","author":"SBS Kambhampati","year":"2020","unstructured":"Kambhampati SBS, Vaishya R, Vaish A. Unprecedented surge in publications related to COVID-19 in the first three months of pandemic: a bibliometric analytic report. J Clin Orthop Trauma. 2020;11(Suppl 3):S304\u20136. https:\/\/doi.org\/10.1016\/j.jcot.2020.04.030.","journal-title":"J Clin Orthop Trauma"},{"issue":"7821","key":"6466_CR2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430\u20136. https:\/\/doi.org\/10.1038\/s41586-020-2521-4.","journal-title":"Nature"},{"key":"6466_CR3","doi-asserted-by":"crossref","unstructured":"Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.","DOI":"10.1136\/bmj.m1985"},{"key":"6466_CR4","doi-asserted-by":"publisher","unstructured":"Seidu S, Gillies C, Zaccardi F, Kunutsor SK, Hartmann-Boyce J, Yates T,Singh AK, Davies MJ, Khunti K. The impact of obesity on severe disease and mortality in people with SARS-CoV-2: A systematic review and meta-analysis. Endocrinol Diabetes Metab. 2020;4(1):e00176. https:\/\/doi.org\/10.1002\/edm2.176. Epub ahead of print.","DOI":"10.1002\/edm2.176"},{"key":"6466_CR5","volume-title":"The Prevalence of Comorbidities and Their Association with Mortality in Patients with COVID-19: A Systematic Review and Meta-Analysis","author":"AK Singh","year":"2020","unstructured":"Singh AK, Gillies CL, Singh R, Singh A, Chudasama Y, Coles B, Seidu S, Zaccardi F, Davies MJ, Khunti K. The Prevalence of Comorbidities and Their Association with Mortality in Patients with COVID-19: A Systematic Review and Meta-Analysis. Available at SSRN 3576854. 2020."},{"issue":"8","key":"6466_CR6","doi-asserted-by":"publisher","first-page":"e0238215","DOI":"10.1371\/journal.pone.0238215","volume":"15","author":"P Ssentongo","year":"2020","unstructured":"Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis. PLoS One. 2020;15(8):e0238215. https:\/\/doi.org\/10.1371\/journal.pone.0238215.","journal-title":"PLoS One"},{"key":"6466_CR7","first-page":"1","volume":"19","author":"RA Mahumud","year":"2020","unstructured":"Mahumud RA, Kamara JK, Renzaho AM. The epidemiological burden of and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a systematic review and meta-analysis. Infection. 2020;19:1\u201321.","journal-title":"Infection"},{"issue":"10","key":"6466_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","volume":"8","author":"E Barron","year":"2020","unstructured":"Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8(10):813\u201322. https:\/\/doi.org\/10.1016\/S2213-8587(20)30272-2.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"6466_CR9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/eurpub\/ckaa150","volume":"30","author":"N Islam","year":"2020","unstructured":"Islam N, Khunti K, Dambha-Miller H, Kawachi I, Marmot M. COVID-19 mortality: a complex interplay of sex, gender and ethnicity. Eur J Pub Health. 2020;30(5):847\u20138. https:\/\/doi.org\/10.1093\/eurpub\/ckaa150.","journal-title":"Eur J Pub Health"},{"issue":"15","key":"6466_CR10","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/cid\/ciaa415","volume":"71","author":"J Lighter","year":"2020","unstructured":"Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infect Dis. 2020;71(15):896\u20137. https:\/\/doi.org\/10.1093\/cid\/ciaa415.","journal-title":"Clin Infect Dis"},{"issue":"10236","key":"6466_CR11","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/S0140-6736(20)31024-2","volume":"395","author":"DA Kass","year":"2020","unstructured":"Kass DA, Duggal P, Cingolani O. Obesity could shift severe COVID-19 disease to younger ages. Lancet (London, England). 2020;395(10236):1544\u20135.","journal-title":"Lancet (London, England)"},{"key":"6466_CR12","doi-asserted-by":"publisher","unstructured":"Tartof SY, Qian L, Hong V, Wei R, Nadjafi RF, Fischer H, et al. Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization. Ann Intern Med. 2020. https:\/\/doi.org\/10.7326\/M20-3742.","DOI":"10.7326\/M20-3742"},{"key":"6466_CR13","doi-asserted-by":"publisher","unstructured":"Fres\u00e1n U, Guevara M, El\u00eda F, Alb\u00e9niz E, Burgui C, Castilla J, et al. Independent role of morbid obesity as a risk factor for COVID-19 hospitalization: a Spanish population-based cohort study. Obesity. 2020. https:\/\/doi.org\/10.1002\/oby.23029.","DOI":"10.1002\/oby.23029"},{"key":"6466_CR14","doi-asserted-by":"publisher","unstructured":"Hendren NS, de Lemos JA, Ayers C, Das SR, Rao A, Carter S, et al. Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. Circulation. 2020. https:\/\/doi.org\/10.1161\/circulationaha.120.051936.","DOI":"10.1161\/circulationaha.120.051936"},{"key":"6466_CR15","doi-asserted-by":"publisher","unstructured":"Czernichow S, Beeker N, Rives-Lange C, Guerot E, Diehl JL, Katsahian S, et al. AP-HP\/Universities\/Inserm COVID-19 research collaboration and AP-HP Covid CDR Initiative. Obesity doubles mortality in patients hospitalized for SARS-CoV-2 in Paris hospitals, France: a cohort study on 5795 patients. Obesity. 2020. https:\/\/doi.org\/10.1002\/oby.23014.","DOI":"10.1002\/oby.23014"},{"issue":"1","key":"6466_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S1473-3099(13)70327-X","volume":"14","author":"JW Dunning","year":"2014","unstructured":"Dunning JW, Merson L, Rohde GG, Gao Z, Semple MG, Tran D, et al. Open source clinical science for emerging infections. Lancet Infect Dis. 2014;14(1):8\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(13)70327-X.","journal-title":"Lancet Infect Dis"},{"key":"6466_CR17","volume-title":"Priority groups for coronavirus (COVID-19) vaccination: advice from the JCVI","author":"Depart of Health and Social Care, UK","year":"2020","unstructured":"Depart of Health and Social Care, UK. Priority groups for coronavirus (COVID-19) vaccination: advice from the JCVI. 2020. https:\/\/www.gov.uk\/government\/publications\/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-2-december-2020\/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-2-december-2020 Accessed 17 Dec 2020."},{"key":"6466_CR18","volume-title":"Health survey for England 2017\u2014adult and child overweight and obesity","author":"A Conolly","year":"2018","unstructured":"Conolly A, Davies B. Health survey for England 2017\u2014adult and child overweight and obesity. Leeds: NHS Digital, NHS; 2018. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/health-survey-for-england\/2017 assessed 12\/11\/2020"},{"key":"6466_CR19","doi-asserted-by":"crossref","unstructured":"Greenhalgh T, Knight M, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370.","DOI":"10.1136\/bmj.m3026"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06466-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06466-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06466-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T04:16:53Z","timestamp":1627705013000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06466-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,31]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6466"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06466-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,31]]},"assertion":[{"value":"16 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for data collection and analysis by ISARIC4C was given by the South Central-Oxford C Research Ethics Committee in England (reference \/SC\/0149), and by the Scotland A Research Ethics Committee (reference 20\/SS\/0028). The ISARIC WHO CCP-UK study was registered at https:\/\/www.isrctn.com\/ISRCTN66726260 and designated an Urgent Public Health Research Study by NIHR. The methods used to collect the human data for this study were completed in accordance with all the relevant guidelines and regulations. Informed consent or proxy consent was collected from all human participants for their data to be included in this study. Further information on the methods to collect data, informed consent and study can be found within the study protocol, which can be found at .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KK is supported by the National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM) and TY by the NIHR Leicester Biomedical Research Centre (BRC). KK is Director for the University of Leicester Centre for BME Health, Trustee of the South Asian Health Foundation, national NIHR ARC lead for Ethnicity and Diversity and a member of Independent SAGE and Chair of the SAGE subgroup on ethnicity and COVID-19. MGS is a member of HMG SAGE COVID-19. MGS reports grants from DHSC NIHR UK, grants from MRC UK, grants from HPRU in Emerging and Zoonotic Infections, University of Liverpool, during the conduct of the study, other from Integrum Scientific LLC, Greensboro, NC, USA, outside the submitted work. Other authors declare no conflicts of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"717"}}